1. Khan MZ, Zahoor M. An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies. Trop Med Infect Dis. 2018;3(2):65.75 [ DOI:10.3390/tropicalmed3020065] [ PMID] [ ] 2. Perez A, Berhe M. Brucella, a bacterium with multiple ways of causing infection. Proc (Bayl Univ Med Cent). 2020;34(1):99-101. [ DOI:10.1080/08998280.2020.1805674] [ PMID] [ ] 3. Jamil T, Khan AU, Saqib M, Muhammad H, Melzer F, Rehman A, et al. Animal and Human Brucellosis in Pakistan. Front Public Health. 2021;9:660508. [ DOI:10.3389/fpubh.2021.660508] [ PMID] [ ] 4. Poveda-Urkixo I, Ramírez GA, Grilló MJ. Kinetics of Placental Infection by Different Smooth Brucella Strains in Mice. Pathogens. 2022;11(3):279. [ DOI:10.3390/pathogens11030279] [ PMID] [ ] 5. Senevirathne A, Hewawaduge C, Lee JH. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge. Vet Res. 2020;51(1):6. [ DOI:10.1186/s13567-020-0735-y] [ PMID] [ ] 6. Khurana SK, Sehrawat A, Tiwari R, Prasad M, Gulati B, Shabbir MZ, et al. Bovine brucellosis - a comprehensive review. Vet Q. 2021;41(1):61-88. [ DOI:10.1080/01652176.2020.1868616] [ PMID] [ ] 7. Al-Mariri A, Al-Hallab L, Alabras R, Kherbik H, Khawajkiah M, et al. Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model. Clin Exp Vaccine Res. 2022;11(1):53-62. [ DOI:10.7774/cevr.2022.11.1.53] [ PMID] [ ] 8. Tavares LM, de Jesus LCL, da Silva TF, F L Barroso, L Batista V, et al. Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model. Front Bioeng Biotechnol. 2020;8:517166. [ DOI:10.3389/fbioe.2020.517166] [ PMID] [ ] 9. Song AA, In LLA, Lim SHE, Rahim RA. A review on Lactococcus lactis: from food to factory. Microb Cell Fact. 2017;16(1):55.
https://doi.org/10.1186/s12934-017-0754-1 [ DOI:10.1186/s12934-017-0669-x] 10. Gómez L, Alvarez F, Betancur D, Oñate A. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus. Vaccine. 2018;36(21):2928-2936. [ DOI:10.1016/j.vaccine.2018.04.014] [ PMID] 11. Gómez L, Llanos J, Escalona E, Sáez E, Álvarez F, Molina R, et al. Multivalent Fusion DNA Vaccine against Brucella abortus. Biomed Res Int. 2017;2017:6535479. [ DOI:10.1155/2017/6535479] [ PMID] [ ] 12. Fatehi Z, Doosti A, and Jami MS. "Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus. Archives of Microbiology. 205.4 (2023): 122. [ DOI:10.1007/s00203-023-03471-6] [ PMID] [ ] 13. Mandel M, Higa A. Calcium-dependent bacteriophage DNA infection. J Mol Biol. 1970;53(1):159-162. doi:10.1016/0022-2836(70)90051-3 [ DOI:10.1016/0022-2836(70)90051-3] [ PMID] 14. Welker DL, Coburn BM, McClatchy JH, Broadbent JR. Multiple pulse electroporation of lactic acid bacteria Lactococcus lactis and Lactobacillus casei. Journal of microbiological methods. 2019 Nov 1;166:105741. [ DOI:10.1016/j.mimet.2019.105741] [ PMID] 15. Mierau I, Olieman K, Mond J, Smid EJ. Optimization of the Lactococcus lactis nisin-controlled gene expression system NICE for industrial applications. Microb Cell Fact. 2005;4:16. doi:10.1186/1475-2859-4-16 [ DOI:10.1186/1475-2859-4-16] [ PMID] [ ] 16. Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr. 2002;41 Suppl 1:I32-7. [ DOI:10.1007/s00394-002-1105-4] [ PMID] 17. Ahmed FE. Genetically modified probiotics in foods. Trends Biotechnol. 2003;21(11):491-7. [ DOI:10.1016/j.tibtech.2003.09.006] [ PMID] 18. Sáez D, Fernández P, Rivera A, Andrews E, Oñate A. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine. 2012;30(7):1283-90. [ DOI:10.1016/j.vaccine.2011.12.088] [ PMID] 19. Tabatabai LB, Pugh GW Jr. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine. 1994;12(10):919-24. [ DOI:10.1016/0264-410X(94)90035-3] [ PMID] 20. Oñate AA, Vemulapalli R, Andrews E, Schurig GG, Boyle S, Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun. 1999;67(2):986-8. [ DOI:10.1128/IAI.67.2.986-988.1999] [ PMID] [ ] 21. Gómez L, Llanos J, Escalona E, Sáez D, Álvarez F, Molina R, et al. Multivalent Fusion DNA Vaccine against Brucella abortus. Biomed Res Int. 2017;2017:6535479. [ DOI:10.1155/2017/6535479] [ PMID] [ ] 22. Sislema-Egas F, Céspedes S, Fernández P, Retamal-Díaz A, Sáez D, Oñate A. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice. Vaccine. 2012; 30(50):7286-91. [ DOI:10.1016/j.vaccine.2012.09.039] [ PMID]
|